Spain · Series B startup

Who invested in ARTHEx Biotech

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$41Mraised across 1 round since 2025, from 1 source

Latest round
Series B, $41MSept 2025
Investors
3
See who backed them

The rounds

  1. Sept 2025

Founders and team

From ARTHEx Biotech's own website: 4 on the team.

  • Arthex BiotechChief Executive Officer
  • Benoit BarteauBoard Member
  • Glenn SblendorioChairman of the Board
  • Sound BioventuresBoard Member

Everyone who backed them

BpifranceGovernment1round
EIC AcceleratorGovernment1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list ARTHEx Biotech as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Invivo PartnersVC firmPer its own site
Invivo Capital PartnersVC firmPer its own site

Quick answers about ARTHEx Biotech

Who invested in ARTHEx Biotech?

ARTHEx Biotech's investors include Bpifrance, EIC Accelerator and U.S. Venture Partners.

How much has ARTHEx Biotech raised?

ARTHEx Biotech has raised $41M across 1 round since 2025.

When did ARTHEx Biotech last raise?

ARTHEx Biotech's most recent round was a Series B of $41M in Sept 2025.

What was ARTHEx Biotech's biggest round?

Its most recent round, $41M in Sept 2025, is also its largest on record.

Who backed ARTHEx Biotech first?

ARTHEx Biotech's first round on record, in Sept 2025, was backed by Bpifrance, EIC Accelerator and U.S. Venture Partners.

What stage is ARTHEx Biotech at?

ARTHEx Biotech's latest named round is a Series B, in Sept 2025.

Where is ARTHEx Biotech based?

ARTHEx Biotech is based in Spain.

Companies like ARTHEx Biotech

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.